Wordt geladen...
Improving systemic breast cancer therapy: time to look beyond the primary tumour?
AIM: Intra and inter tumour heterogeneity is a known feature in cancer because tumour cells undergo changes at genetic and epigenetic level as they spread from their primary tumour site. Adjuvant treatment protocols in breast cancer are currently based on the biological characteristics of the primar...
Bewaard in:
| Gepubliceerd in: | Facts Views Vis Obgyn |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Universa Press
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5058414/ https://ncbi.nlm.nih.gov/pubmed/27729970 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|